Loading the company…
Loading the company…
Families: Breast reconstruction, Cataract & MIGS.
All companies · Product and company coverage
In the last ten years FDA made 52 decisions for Allergan (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2017 (20). The latest was on 2026-09-29.
| Family | Decisions on record |
|---|---|
| Breast reconstruction | 140 |
| Cataract & MIGS | 4 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-29 | PMA | P020056-S064 | Natrelle Silicone-Filled Breast Implants and Natrelle INSPIRA Silicone-Filled Breast Implants · Labeling Change - PAS |
| 2024-12-16 | PMA | P020056-S065 | NATRELLE Silicone-Filled Breast Implants · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2024-12-16 | PMA | P990074-S054 | NATRELLE Saline-Filled Breast Implants · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2024-08-16 | PMA | P020056-S050 |
| NATRELLE Silicone-Filled Breast Implants · Postapproval Study Protocol |
| 2024-06-21 | PMA | P020056-S063 | NATRELLE® Silicone-Filled Breast Implants · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Allergan.